Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,7213,740 of 20,252 grants

Active NON-SBIR/STTR RPGS
Development and Implementation of Advanced Technologies for Cancer Metabolism Research
NATIONAL CANCER INSTITUTE Sanford Burnham Prebys Medical Discovery... United States 2023 – 2028

PROJECT SUMMARY This proposal requests support for my position as the Director of the Cancer Metabolism Core at Sanford Burnham Prebys Medical Discovery Institute (SBP). The Core i...

$1.42M
USD
Active NON-SBIR/STTR RPGS
Optimizing a Social Connectedness Intervention for Young Adults with Cancer
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Young adults with cancer need tailored behavioral interventions to improve their psychosocial health. Any cancer diagnosis in early adulthood can create de...

$6.8M
USD
Active NON-SBIR/STTR RPGS
Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

SUMMARY Hormone receptor (HR)+ breast cancer (BC) causes the majority of BC-related deaths in the US, reflecting an unmet need for innovative therapeutic approaches. Indeed, resist...

$7.03M
USD
Active NON-SBIR/STTR RPGS
Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors
NATIONAL CANCER INSTITUTE University of Minnesota United States 2023 – 2030

During the last 2.5 decades, I have led clinical efforts to develop novel NK cell immunotherapy strategies to treat cancer by advancing lab-based discoveries in the areas of natura...

$9.29M
USD
Active NON-SBIR/STTR RPGS
Tailored prostate cancer screening: addressing USPSTF priority research gaps in a racially-diverse study population
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT Screening for prostate cancer (PCa) is highly controversial, as accumulated evidence indicates that widespread, routine prostate-specific antigen (PSA)-based screening red...

$6.8M
USD
Active NON-SBIR/STTR RPGS
Etiologic Heterogeneity Between Molecular Subtypes of Prostate Cancer
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2028

PROJECT SUMMARY This proposed project investigates the hypothesis that risk factors for prostate cancer differ by molecular subtype of the tumor. It addresses the conundrum that pr...

$7.56M
USD
Completed NON-SBIR/STTR RPGS
Epitranscriptomic control of ROS
NATIONAL CANCER INSTITUTE Suny Polytechnic Institute United States 2023 – 2025

Maintenance of the GSH redox cycle is reliant on the activities of selenocysteine-containing GSH metabolizing enzymes which play fundamental roles in chemoprevention. Selenocystein...

$2.97M
USD
Active NON-SBIR/STTR RPGS
SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data
NATIONAL CANCER INSTITUTE University of Minnesota United States 2023 – 2027

Advances in cancer prevention, diagnosis, and treatment have dramatically improved long-term survival of those diagnosed with breast cancer. However, this success has been tempered...

$3M
USD
Completed NON-SBIR/STTR RPGS
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation
NATIONAL CANCER INSTITUTE University of Kentucky United States 2023 – 2026

ABSTRACT (R01CA251663) Radiation therapy (RT) is widely used to treat localized prostate cancer (PCa). However, cancer cells often develop resistance to RT through unknown mechanis...

$616.5K
USD
Active TRAINING, INDIVIDUAL
Elucidating mechanisms of therapy response in BRCA2 mutant prostate cancers
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2026

ABSTRACT Prostate cancer is the most common non-skin malignancy in men and is projected to cause 34,500 deaths in 2022 in the United States alone. Sequencing studies of advanced le...

$397.1K
USD
Active NON-SBIR/STTR RPGS
Molecular mechanisms and therapeutic targeting of activated NRF2 signaling in MiT/TFE translocation renal cell carcinoma
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY Renal cell carcinoma (RCC) is one of the top ten most common cancers worldwide and is comprised of multiple distinct histologies. One particularly aggressive subtyp...

$4.65M
USD
Completed OTHER RESEARCH-RELATED
Functional and Pharmacologic Investigation of the NUP98 Fusion Oncoprotein Interactome
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2023 – 2025

PROJECT SUMMARY Chromosomal translocations involving Nucleoporin 98 (NUP98) are observed in approximately 5% of pediatric acute myeloid leukemia (AML) and are associated with resis...

$1.41M
USD
Active NON-SBIR/STTR RPGS
Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors
NATIONAL CANCER INSTITUTE University of Minnesota United States 2023 – 2030

During the last 2.5 decades, I have led clinical efforts to develop novel NK cell immunotherapy strategies to treat cancer by advancing lab-based discoveries in the areas of natura...

$8.82M
USD
Active NON-SBIR/STTR RPGS
Optimizing a Social Connectedness Intervention for Young Adults with Cancer
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Young adults with cancer need tailored behavioral interventions to improve their psychosocial health. Any cancer diagnosis in early adulthood can create de...

$6.45M
USD
Active NON-SBIR/STTR RPGS
Nuclear envelope and predisposition to hepatic neoplasia
NATIONAL CANCER INSTITUTE Hackensack University Medical Center United States 2023 – 2028

PROJECT SUMMARY Chronic liver diseases such as nonalcoholic steatohepatitis significantly increase the risk of cirrhosis and hepatocellular carcinoma (HCC). However, the underlying...

$3.85M
USD
Active NON-SBIR/STTR RPGS
Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
NATIONAL CANCER INSTITUTE Veterans Education/Res/Assn/North/Ne United States 2023 – 2028

Project Summary There are ~800,000 bladder cancer survivors in the US, making it the fifth most prevalent cancer. This study focuses on the largest group of patients with bladder c...

$5.66M
USD
Active NON-SBIR/STTR RPGS
Tailored prostate cancer screening: addressing USPSTF priority research gaps in a racially-diverse study population
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT Screening for prostate cancer (PCa) is highly controversial, as accumulated evidence indicates that widespread, routine prostate-specific antigen (PSA)-based screening red...

$5.39M
USD
Active NON-SBIR/STTR RPGS
ATR: targeting mechanical stress induced EMT and immune suppression in triple negative breast cancer
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2023 – 2028

PROJECT DESCRIPTION/ABSTRACT Therapeutically resistant triple negative breast cancer (TNBC) is characterized by mesenchymal features that facilitate immune evasion and disease prog...

$3.51M
USD
Active NON-SBIR/STTR RPGS
HLA B44 motif neoepitopes in NSCLC: Evaluating their effects on the TME and adding them to established markers in a model to predict durable benefit from PD- 1 inhibition with and without chemotherapy
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2023 – 2028

PROJECT SUMMARY Lung cancer is the leading cause of cancer related deaths in the United States and the World. We recently demonstrated that programmed cell death 1 (PD-1) inhibitor...

$5.92M
USD
Active NON-SBIR/STTR RPGS
A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates
NATIONAL CANCER INSTITUTE Columbia University New York Morningside United States 2023 – 2026

PROJECT SUMMARY Protein tyrosine phosphorylation is a common mechanism for relaying essential information in animal cells, and many cancers are driven by aberrant tyrosine phosphor...

$1.84M
USD